Pharvaris N.V. (PHVS) vs Vericel Corporation (VCEL)
- Pharvaris N.V. PHVS 27.82 −6.14%
- Vericel Corporation VCEL 40.13 −2.17%
Pharvaris N.V. and Vericel Corporation are both Biotechnology companies. Pharvaris N.V. and Vericel Corporation are of similar size ($2.1B and $2.1B). Pharvaris N.V. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 83.6×. Vericel Corporation has the higher net margin (7.91% vs 0.00%) and the higher return on invested capital (5.49% vs 0.00%). Across the 15 metrics below, Vericel Corporation leads on 13 and Pharvaris N.V. on 2.
Valuation
Profitability
| Metric | PHVS | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 74.56% | 65.16% |
| Operating margin | 0.00% | 5.95% | 0.00% |
| Net margin | 0.00% | 7.91% | 0.00% |
| Free cash flow margin | 0.00% | 20.13% | 0.00% |
| Return on equity | (71.50%) | 7.16% | (56.36%) |
| Return on assets | (64.43%) | 5.16% | (48.04%) |
| Return on invested capital | 0.00% | 5.49% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack